Test and Measurement Equipment Market Size, Share and Trends 2026 to 2035

Numerous market players are actively entering this market, drawn by partnerships, R&D, and business expansion. Numerous equipment manufacturers, such as IKM Instrutek (Norway), Uni-Trend Technology (China), Mextech Technologies, and others, have started investing rapidly in developing advanced testing equipment in different parts of the world.

Various startup brands are engaged in developing high-quality testing and measurement solutions across the world. The prominent startup companies dealing in measurement equipment consist of CALYPSO instruments, Polar Signals, STPI SMART Lab, and some others.

Between 2025 and 2030, this market is expected to rise significantly due to the technological advancements in the aerospace and defence sector, coupled with the rapid expansion of the industrial sector globally.

Numerous market players are actively entering this market, drawn by partnerships, R&D, and business expansion. Numerous equipment manufacturers, such as IKM Instrutek (Norway), Uni-Trend Technology (China), Mextech Technologies, and others, have started investing rapidly in developing advanced testing equipment in different parts of the world.

Various startup brands are engaged in developing high-quality testing and measurement solutions across the world. The prominent startup companies dealing in measurement equipment consist of CALYPSO instruments, Polar Signals, STPI SMART Lab, and some others.

The systemic scleroderma segment held the dominant share of the scleroderma therapeutics market in 2025. The segment growth is attributed to higher prevalence and greater severity of systemic scleroderma. The increased awareness and advanced diagnosis are driving the growth of the segment. Moreover, an aging population is contributing to the expansion. Systemic scleroderma improves morbidity and mortality by directly affecting inner organs like lungs and kidneys. The growing investments of pharmaceutical companies in the development of innovative treatments for systemic scleroderma.

In March 2024, Cabaletta Bio received the FDA-granted Orphan Drug Designation (ODD) for its CABA-201, an investigational therapy for scleroderma. CABA-201 is being developed as a treatment for autoimmune diseases, and it is a CD19-CAR T cell therapy.
In November 2024, the Scleroderma Research Foundation (SRF) published a peer-reviewed article on CONQUEST, a highly innovative platform clinical study that accelerates the development of new therapies for systemic sclerosis. CONQUEST focuses on early, active systemic sclerosis with interstitial lung disease (SSc-ILD), a serious complication that is the leading cause of death in scleroderma.

However, the localized scleroderma segment is anticipated to grow at the highest CAGR in the scleroderma therapeutics market during the forecast period. Localized scleroderma has properties of limited skin involvement. Localized scleroderma can mostly be treated by utilizing topical medications and phototherapy. Continuous innovations in the development of novel treatments for localized scleroderma, like biologics and small molecules, are fueling the segment expansion. Additionally, the ability of localized scleroderma to be cured by using systemic immunosuppressive therapy drives cutting-edge research in the treatments.

The healthcare segment dominated the test and measurement equipment market with the largest share in 2025. The growth of the segment is attributed to the rising implementation of tests and measurements in the healthcare sector to improve patient and treatment outcomes. Testing and measurement are used to simplify complex and efficient diagnostics to help with the treatment. It also helps in the testing of preventive vaccines and medications. The continuous research on the development and launch of the latest medical devices, personal emergency reporting systems, and patient monitoring systems drives the demand for testing and measurement in the healthcare industry. Additionally, the rising investment in the development of the healthcare industry is further driving the demand for test and measurement equipment in the segment. The automotive and transportation segment is expecting significant growth in the market during the forecast period. The growth of the segment is owing to the rising demand for the automotive industry by the population due to the rising disposable income and the rising tendency to have their own transportation system, which is driving the growth of the automotive and transportation industry. Test and measurement equipment plays an important role in the automotive industry; it is used in every stage of automobile manufacturing, from development to production, quality checking and assurance, safety testing, conformity, workshops, and recycling. Furthermore, the rising advancements in automotive technologies, integration of smart features, and rising competition in the automobile industry are collectively contributing to the expansion of the test and measurement equipment market.

Latin America held a considerable share of the industry. The growing demand for high-quality measurement equipment from the automotive sector in several nations, including Brazil, Argentina, Peru, and some others, has driven the market expansion. Additionally, numerous government initiatives aimed at mandating advanced testing equipment in the manufacturing industry are expected to drive the growth of the test and measurement equipment market in this region.

The Middle East and Africa held a notable share of the market. The rising sales of GPTE in numerous countries, including the UAE, Saudi Arabia, South Africa, Qatar, and some others, has driven the market expansion. Also, partnerships among market players and tech providers to develop high-quality testing equipment are expected to boost the growth of the test and measurement equipment market in this region.

Rohde & Schwarz is a German technology group headquartered in Munich, focusing on three main divisions: Test & Measurement, Technology Systems, and Networks & Cybersecurity. The company develops, produces, and markets products and solutions for industrial, regulatory, and government customers, aiming to foster technological and digital sovereignty.

Anritsu is a Japanese multinational corporation that develops, manufactures, and sells telecommunications and electronic measurement solutions, as well as quality assurance systems. The company's business segments include Test and Measurement, Product Quality Assurance (PQA), Environmental Measurement, and Sensing and Devices.

Advantest is a Japanese company that is a leading global manufacturer of automatic test equipment (ATE) for the semiconductor industry. Advantest is headquartered in Tokyo and provides systems for testing a wide range of semiconductors, including SoC, memory, and RF test systems, and serves companies in the communications and consumer electronics industries.

EXFO is a Canadian company that develops and supplies a wide range of test, monitoring, and analytics solutions for telecommunications networks, including fiber, 5G, and cloud infrastructure. This company provides intelligent hardware, software, and services to customers like service providers and webscale companies to help them transform and manage their networks.

OWON Technology is a Chinese Electronic Manufacturing Service (EMS) provider and Original Design Manufacturer (ODM) that specializes in IoT and smart home solutions, as well as test equipment and electronic displays. It offers a wide range of services from product research and development to manufacturing for customized and standardized products.

GW Instek, or Good Will Instrument Co., Ltd, is a Taiwanese manufacturer of electronic test and measurement instruments founded in 1975. The company is a leading global provider of affordable and reliable equipment for a wide range of industries, with a product portfolio that includes oscilloscopes, spectrum analyzers, signal sources, and power supplies.